The American Physiological Society Press Release

press release logo

APS Contact: APS Communications Office


Phone: 301.634.7209

Twitter: @APSPhysiology

The Down Side of Your Sweet and Salty Addiction: Rapid Onset High Blood Pressure?

Researchers find the synergy of fructose with a high-salt diet a recipe for hypertension, kidney problems

Consumption of fructose, a fruit-derived sugar present in many sweetened beverages and processed foods, has been associated with epidemic levels of diabetes, obesity, metabolic syndrome and hypertension in the U.S. and around the world. New research presented today at the Experimental Biology 2016 meeting in San Diego further supports this link, finding that high levels of fructose similar to amounts consumed within the American diet may predispose individuals to fast-onset, salt-sensitive hypertension.

“A majority of American adults consume 10 percent or more of total calories from added sugars with a subset taking in more than 25 percent of total calories from added sugars,” said lead author Kevin Gordish, PhD. Because beverages are the most common source of added sugars in the American diet, the research team gave rats drinking water with 20 percent fructose—to simulate excessive human soft-drink consumption—and compared them with rats who received plain water in addition to their food for two weeks. During the second week, the rats receiving 20 percent fructose were also given additional salt in their diets.

“The specific combination of fructose and high salt introduced in the second week rapidly increased blood pressure, resulting in hypertension. Fructose-linked hypertension was associated with increased sodium retention, decreased sodium excretion and diminished factors that help rid the body of excess salt. This observation of fructose-linked hypertension was only seen a diet with fructose and high salt and not a normal salt diet,” Gordish said. “Fructose intake, similar to amounts consumed within the American diet, predisposed normal rats to a rapid onset of salt-sensitive hypertension. Fructose-linked hypertension was unambiguously due to fructose (and not glucose). Further, fructose had distinct deleterious effects in the kidney not seen with the same amount of glucose.”

The results have implications for the U.S. in general and certain ethnic groups such as African Americans, who have a high rate of incidence of salt-sensitive hypertension, in particular. Overall, these findings raise concern about the amount of fructose and salt found in the American diet.

Gordish, a postdoctoral fellow at the Henry Ford Hospital in Detroit, will present “Enhanced Dietary Fructose Rapidly Induces Salt-Sensitive Hypertension in Rats” as part of the poster session “Cross-Talk between Salt and Other Factors in Hypertension” on Tuesday, April 5, from 12:45 to 3 p.m. in the Sails Pavilion of the San Diego Convention Center.

NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact Stacy Brooks or (301) 634-7209.

Full Abstract

Fructose consumption is associated with increased sodium reabsorption, increased formation of reactive oxygen species, and the development of hypertension. In normal rats, 20% dietary fructose supplementation induces hypertension within 8–12 weeks. We hypothesized a diet combining 20% fructose supplemented with high salt (4% NaCl) would induce abnormal sodium retention, increased oxidative stress and accelerate the development of elevated blood pressure. Rats weighing 200–225 g were pre-trained for 2 weeks for noninvasive tail cuff blood pressure measurements and then placed in metabolic caging. Rats were pair-fed for 2 weeks with one of 5 different diets: 1) control group (0.4% NaCl), 2) high salt chow group (4% NaCl), 3) 20% fructose group (in the drinking water), and 4) 20% fructose plus high salt group, 5) 20% glucose plus high salt group (n’s = 9,5,9,18, 9). Blood pressure, urinary sodium excretion and cumulative sodium balance were measured over 2 weeks and urinary nitric oxide and 8Isoprostane excretion, as a marker for reactive oxygen species, during the final two days. High salt chow replaced normal chow at the beginning of the second week. By the end of the protocol, systolic blood pressure was unchanged in control group (121±2 to 122±2 mmHg) as well as the high salt group (122±2 to 122±1 mmHg). 20% fructose alone had no effect on blood pressure over the 2 weeks (121±1 to 125±1 mmHg). However, blood pressure significantly increased in the 20% fructose plus high salt group (125 to 140 mmHg p<0.001). The increased blood pressure was concomitant with increased positive cumulative sodium balance. During the final week mean urinary sodium excretion in the high salt and 20% fructose plus high salt groups were 5-6 fold higher than normal salt controls (p<0.001): 1.13±0.07, 7.67±0.31, 1.20±0.10, 5.33±0.21, and 6.12±0.77 mEq/24 hrs, respectively. Despite similar consumption, urinary sodium excretion in the 20% fructose plus high salt group was significantly lower than the high salt group (p<0.0001). Urinary 8Isoprostane excretion was significantly higher in the high salt, 20% fructose, and 20% fructose plus high salt groups compared to control: 16.4±1.3, 29.5±2.5, 32.2±3.9, 31.2±2.5 ng/24 hrs, (p<0.001). Nitric oxide excretion was impaired in the 20% fructose and high salt group compared to the high salt group and 20% glucose and high salt (p<0.05).

Our results suggest enhanced fructose and salt consumption increases sodium retention and oxidative stress. High salt can induce elevations in blood pressure in 20% fructose-fed rats within just one week. Increased blood pressure appears to associate with increased sodium retention and positive cumulative sodium balance. Overall, fructose combined with high salt in the diet contributes to the accelerated development of salt-sensitive hypertension.

About Experimental Biology 2016

Experimental Biology is an annual meeting comprised of more than 14,000 scientists and exhibitors from six sponsoring societies and multiple guest societies. With a mission to share the newest scientific concepts and research findings shaping clinical advances, the meeting offers an unparalleled opportunity for exchange among scientists from across the United States and the world who represent dozens of scientific areas, from laboratory to translational to clinical research.


Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents more than 10,500 members and publishes 15 peer-reviewed journals with a worldwide readership.



Raising Dietary Potassium to Sodium Ratio Helps Reduce Heart, Kidney Disease

Released February 21, 2017 - Reducing sodium (salt) in the diet has been recommended to lower blood pressure and the risk of heart disease. However, in a new review article, University of Southern California researchers found that increasing dietary potassium is as important to improving the risk factors for cardiovascular and kidney disease as limiting dietary sodium. The article is published ahead of print in the American Journal of Physiology—Endocrinology and Metabolism.

Nobel Laureate, Esteemed Researchers Participate in APS President’s Symposium

Released April 18, 2017 - APS President Jane Reckelhoff, PhD, of the University of Mississippi Medical Center, has developed an engaging President’s Symposium Series to be presented during the 2017 Experimental Biology meeting in Chicago. Three symposia will focus on the theme “Research Advances in Sex/Gender and Developmental Programming of Chronic Diseases.”

Researchers Explore a Better Way to Measure Blood Pressure

Released August 12, 2017 - Automatic blood pressure devices are often used to assess blood pressure levels at home and in the clinic. But these automatic devices are prone to significant errors, sometimes leading to the prescription of blood pressure-lowering medications to patients who don’t actually need them. Researchers at the Jerusalem College of Technology and the Shaare Zedek Medical Center in Israel have developed a method to more accurately measure systolic blood pressure. They will present their findings at the Cardiovascular Aging: New Frontiers and Old Friends conference in Westminster, Colo.